Edge Pharmacy Services Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Colchester, VT USA
Total Funding:N/A
Founded:2013
Lead Investor(s):N/A

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Edge Pharmacy Services's estimated annual revenue is currently $13.5M per year.
  • Edge Pharmacy Services's estimated revenue per employee is $270,000

Employee Data

  • Edge Pharmacy Services has 50 Employees.
  • Edge Pharmacy Services grew their employee count by 39% last year.
  • Edge Pharmacy Services currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$217.1M804N/AN/A-N/A
#2
$49.1M182N/AN/A-N/A
#3
$1267.9M4696N/AN/A-N/A
#4
$95.6M354N/AN/A-N/A
#5
$140.7M521N/AN/A-N/A
#6
$63.7M236N/AN/A-N/A
#7
$50.8M188N/AN/A-N/A
#8
$13.5M5039%N/A-N/A
#9
$12.4M4618%N/A-N/A
#10
$200.3M742N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Edge Pharmacy Services is a pharmaceutical sterile and non-sterile 503B Outsourcing Facility offering high quality, innovative solutions for the health care community. The world-class scientific, pharmacy, and engineering staff at Edge understand the challenges your organization, whether large or small, are tackling. As your compliance partner, we are dedicated to providing turnkey 503B outsourcing with the highest level of quality, easy ordering, simple logistics, and excellent customer support.

keywords:Biotechnology,Healthcare,Healthcare Providers

50

Number of Employees

$13.5M

Revenue (est)

1

Current Jobs

39%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Edge Pharmacy Services News

18-Feb-19 - New Allergy Treatment Program Aims to Improve Patient Care and

Edge Pharmacy Services, a leader in the 503B Outsourcing industry, is excited to announce an investment in Xtract Solutions, an allergy

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$12.3M5016%N/A-N/A
#2
N/A5273%N/A-N/A
#3
$12.7M5313%N/A-N/A
#4
N/A536%N/A-N/A
#5
$9.2M5531%N/A-N/A